Rafaela Diana Cojan

Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study.

E. Silvestri, G. Emmi, G. Di Scala, 2019, Journal of autoimmunity.

Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial.

A. Vaglio, E. Silvestri, G. Emmi, 2018, Autoimmunity reviews.